Skip to main content
. Author manuscript; available in PMC: 2016 Oct 1.
Published in final edited form as: Invest New Drugs. 2015 Jun 20;33(5):1040–1047. doi: 10.1007/s10637-015-0261-3

Figure 4. Swimmer’s Plot of Progression Free and Overall Survival.

Figure 4

Chart depicts progression free and overall survival of each individual patient as a function of time as measured in weeks. Patients are divided with those having received a prior mTOR inhibitor on the top and those without prior mTOR inhibition towards the bottom. Symbols indicate whether patients were still living at the time of data cut-off; no patients remained on study.

Note: mTOR, mammalian target of rapamycin; PFS, progression free survival; OS, overall survival; Wks, weeks